523 related articles for article (PubMed ID: 24055429)
1. The predictive value of positive urine cytology for outcomes following radical nephroureterectomy in patients with primary upper tract urothelial carcinoma: a multi-institutional study.
Tanaka N; Kikuchi E; Kanao K; Matsumoto K; Shirotake S; Kobayashi H; Miyazaki Y; Ide H; Obata J; Hoshino K; Hayakawa N; Kosaka T; Oyama M; Miyajima A; Momma T; Nakagawa K; Jinzaki M; Nakajima Y; Oya M
Urol Oncol; 2014 Jan; 32(1):48.e19-26. PubMed ID: 24055429
[TBL] [Abstract][Full Text] [Related]
2. C-reactive protein: a biomarker of survival in patients with localized upper tract urothelial carcinoma treated with radical nephroureterectomy.
Obata J; Kikuchi E; Tanaka N; Matsumoto K; Hayakawa N; Ide H; Miyajima A; Nakagawa K; Oya M
Urol Oncol; 2013 Nov; 31(8):1725-30. PubMed ID: 23141922
[TBL] [Abstract][Full Text] [Related]
3. Effect of tumor size on recurrence-free survival of upper tract urothelial carcinoma following surgical resection.
Espiritu PN; Sverrisson EF; Sexton WJ; Pow-Sang JM; Poch MA; Dhillon J; Spiess PE
Urol Oncol; 2014 Jul; 32(5):619-24. PubMed ID: 24495448
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of non-muscle-invasive bladder tumor history in patients with upper urinary tract urothelial carcinoma.
Milojevic B; Djokic M; Sipetic-Grujicic S; Grozdic Milojevic I; Vuksanovic A; Nikic P; Vukovic I; Djordjevic D; Bumbasirevic U; Tulic C
Urol Oncol; 2013 Nov; 31(8):1615-20. PubMed ID: 22521771
[TBL] [Abstract][Full Text] [Related]
5. Independent prognostic factors for initial intravesical recurrence after laparoscopic nephroureterectomy for upper urinary tract urothelial carcinoma.
Liu Y; Lu J; Hong K; Huang Y; Ma L
Urol Oncol; 2014 Feb; 32(2):146-52. PubMed ID: 23628312
[TBL] [Abstract][Full Text] [Related]
6. Predicting clinical outcomes after radical nephroureterectomy for upper tract urothelial carcinoma.
Cha EK; Shariat SF; Kormaksson M; Novara G; Chromecki TF; Scherr DS; Lotan Y; Raman JD; Kassouf W; Zigeuner R; Remzi M; Bensalah K; Weizer A; Kikuchi E; Bolenz C; Roscigno M; Koppie TM; Ng CK; Fritsche HM; Matsumoto K; Walton TJ; Ehdaie B; Tritschler S; Fajkovic H; Martínez-Salamanca JI; Pycha A; Langner C; Ficarra V; Patard JJ; Montorsi F; Wood CG; Karakiewicz PI; Margulis V
Eur Urol; 2012 Apr; 61(4):818-25. PubMed ID: 22284969
[TBL] [Abstract][Full Text] [Related]
7. Urothelial carcinoma at the uretero-enteric junction: multi-center evaluation of oncologic outcomes after radical nephroureterectomy.
Youssef RF; Shariat SF; Lotan Y; Cost N; Wood CG; Sagalowsky AI; Zigeuner R; Langner C; Chromecki TF; Montorsi F; Bolenz C; Margulis V
Urol Oncol; 2013 Jul; 31(5):676-81. PubMed ID: 21704538
[TBL] [Abstract][Full Text] [Related]
8. Preoperative positive voided urine cytology predicts poor clinical outcomes in patients with upper tract urothelial carcinoma undergoing nephroureterectomy.
Liu W; Wang Z; Liu S; Yao Y; Liu Y; Zhang G
BMC Cancer; 2020 Nov; 20(1):1113. PubMed ID: 33198698
[TBL] [Abstract][Full Text] [Related]
9. Prognostic relevance of postoperative platelet count in upper tract urothelial carcinoma after radical nephroureterectomy.
Gakis G; Fritsche HM; Hassan F; Kluth L; Miller F; Soave A; Otto W; Schwentner C; Todenhöfer T; Dahlem R; Burger M; Fisch M; Stenzl A; Aziz A; Rink M
Eur J Cancer; 2014 Oct; 50(15):2583-91. PubMed ID: 25088206
[TBL] [Abstract][Full Text] [Related]
10. Intravesical seeding of upper urinary tract urothelial carcinoma cells during nephroureterectomy: an exploratory analysis from the THPMG trial.
Ito A; Shintaku I; Satoh M; Ioritani N; Tochigi T; Numata I; Namima T; Kambe K; Kyan A; Ueno S; Katoh S; Adachi H; Yamashita S; Yamaguchi T; Arai Y;
Jpn J Clin Oncol; 2013 Nov; 43(11):1139-44. PubMed ID: 24006504
[TBL] [Abstract][Full Text] [Related]
11. Muscle-invasive bladder cancer developing after nephroureterectomy for upper urinary tract urothelial carcinoma.
Kim KH; You D; Jeong IG; Hong JH; Ahn H; Kim CS
Urol Oncol; 2013 Nov; 31(8):1643-9. PubMed ID: 22591745
[TBL] [Abstract][Full Text] [Related]
12. Impact of preoperative anemia on oncologic outcomes of upper tract urothelial carcinoma treated with radical nephroureterectomy.
Rink M; Sharifi N; Fritsche HM; Aziz A; Miller F; Kluth LA; Ngamsri T; Dahlem R; Chun FK; Shariat SF; Stenzl A; Fisch M; Gakis G
J Urol; 2014 Feb; 191(2):316-22. PubMed ID: 24036235
[TBL] [Abstract][Full Text] [Related]
13. Macroscopic sessile tumor architecture is a pathologic feature of biologically aggressive upper tract urothelial carcinoma.
Fritsche HM; Novara G; Burger M; Gupta A; Matsumoto K; Kassouf W; Sircar K; Zattoni F; Walton T; Tritschler S; Baba S; Bastian PJ; Martínez-Salamanca JI; Seitz C; Otto W; Wieland WF; Karakiewicz PI; Ficarra V; Hartmann A; Shariat SF
Urol Oncol; 2012 Sep; 30(5):666-72. PubMed ID: 20933445
[TBL] [Abstract][Full Text] [Related]
14. High rates of advanced disease, complications, and decline of renal function after radical nephroureterectomy.
Raman JD; Lin YK; Kaag M; Atkinson T; Crispen P; Wille M; Smith N; Hockenberry M; Guzzo T; Peyronnet B; Bensalah K; Simhan J; Kutikov A; Cha E; Herman M; Scherr D; Shariat SF; Boorjian SA
Urol Oncol; 2014 Jan; 32(1):47.e9-14. PubMed ID: 24140248
[TBL] [Abstract][Full Text] [Related]
15. A multi-institutional validation of the prognostic value of the neutrophil-to-lymphocyte ratio for upper tract urothelial carcinoma treated with radical nephroureterectomy.
Tanaka N; Kikuchi E; Kanao K; Matsumoto K; Shirotake S; Miyazaki Y; Kobayashi H; Kaneko G; Hagiwara M; Ide H; Obata J; Hoshino K; Hayakawa N; Kosaka T; Hara S; Oyama M; Momma T; Nakajima Y; Jinzaki M; Oya M
Ann Surg Oncol; 2014 Nov; 21(12):4041-8. PubMed ID: 24912614
[TBL] [Abstract][Full Text] [Related]
16. Influence of previous or synchronous bladder cancer on oncologic outcomes after radical nephroureterectomy for upper urinary tract urothelial carcinoma.
Pignot G; Colin P; Zerbib M; Audenet F; Soulié M; Hurel S; Delage F; Irani J; Descazeaud A; Droupy S; Rozet F; Phé V; Ruffion A; Long JA; Crouzet S; Houlgatte A; Bigot P; Guy L; Faïs PO; Rouprêt M;
Urol Oncol; 2014 Jan; 32(1):23.e1-8. PubMed ID: 23403206
[TBL] [Abstract][Full Text] [Related]
17. Surgical management of the distal ureter during radical nephroureterectomy is an independent predictor of oncological outcomes: results of a current series and a review of the literature.
Krabbe LM; Westerman ME; Bagrodia A; Gayed BA; Khalil D; Kapur P; Shariat SF; Raj GV; Sagalowsky AI; Cadeddu JA; Lotan Y; Margulis V
Urol Oncol; 2014 Jan; 32(1):54.e19-26. PubMed ID: 24360665
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic Ureterorenoscopy Is Associated with Increased Intravesical Recurrence following Radical Nephroureterectomy in Upper Tract Urothelial Carcinoma.
Sung HH; Jeon HG; Han DH; Jeong BC; Seo SI; Lee HM; Choi HY; Jeon SS
PLoS One; 2015; 10(11):e0139976. PubMed ID: 26556239
[TBL] [Abstract][Full Text] [Related]
19. The impact of previous ureteroscopic tumor ablation on oncologic outcomes after radical nephrouretectomy for upper urinary tract urothelial carcinoma.
Gurbuz C; Youssef RF; Shariat SF; Lotan Y; Wood CG; Sagalowsky AI; Zigeuner R; Kikuchi E; Weizer A; Raman JD; Remzi M; Roscigno M; Montorsi F; Bolenz C; Kassouf W; Margulis V
J Endourol; 2011 May; 25(5):775-9. PubMed ID: 21388245
[TBL] [Abstract][Full Text] [Related]
20. Risk factors for bladder cancer recurrence after nephroureterectomy for upper tract urothelial tumors: results from the Canadian Upper Tract Collaboration.
Fradet V; Mauermann J; Kassouf W; Rendon R; Jacobsen N; Fairey A; Izawa J; Kapoor A; Black P; Tanguay S; Chin J; So A; Lattouf JB; Bell D; Saad F; Sheyegan B; Drachenberg D; Cagiannos I; Lacombe L
Urol Oncol; 2014 Aug; 32(6):839-45. PubMed ID: 24856978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
